In addition, the expression levels of CD44v8-10 and U2AF2 are significantly higher in primary melanoma than in dysplastic nevi and are further increased in metastatic melanoma [139], a crucial milestone during melanoma progression [140]. This evidence concerns the gene U2AF2 and melanoma.